Abstract:BackgroundDespite the significant advances in life science, it still takes decades to translate a basic drug discovery into a cure for human disease. To accelerate the process from "bench-to-bedside", interdisciplinary research (especially research involving both basic research and clinical research) has been strongly recommend by many previous studies. However, the patterns and the roles of the interdisciplinary characteristics in drug research have not been deeply examined in extant studies.ObjectiveThe purpose of this study was to characterize interdisciplinarity in drug research from the perspective of translational science, and to examine the role of different kinds of interdisciplinary characteristics in translational research for drugs.MethodsIn this paper, we analyze the interdisciplinary of drug research from a novel bibliometric perspective, i.e., a translational science perspective. 18 FDA approved drugs belonging to 6 categories are used as the research proxies. We propose four bibliometric indicators (i.e., Diversity of Research, Symmetry of Research, Persistence of Research and Stability of Research) for characterizing interdisciplinarity in drug research at both the macro and micro levels. We also design a bibliometric indicator (i.e., Translation Intensity) for quantifying the result of a drug's translation. Correlation analysis was also used to examine the relationships between these interdisciplinary characteristics of drug research and the translation intensity of drugs.ResultsMultidisciplinary research (especially the research involving both basic and clinical disciplines) is still rare for all the 18 drugs and they generally occurred later than intra-disciplinary research in the timelines of drug research. The four interdisciplinary characteristics of drug research and the translation intensity of drugs both vary according to drugs. At the macro level, the diversity and symmetry of research have evident positive relationships with the translation intensity of drugs. At the micro level, the persistence of all seven kinds of research positively correlated with the translation intensity of drugs; and the persistence of multidisciplinary research have stronger relationships with the translation intensity of drugs than those of intra-disciplinary research except for the research within the cell/molecular discipline (CC research), which showed the most impressive correlations with the translation intensity of drugs. In addition, the stability of all kinds of research did not show a significant influence on the translation intensity of drugs.ConclusionsInterdisciplinary research engaging both basic science and clinical science should be encouraged in translational research for drugs. The basic research within the cell/molecular discipline needs more persistence to shorten the translational lags in drug research. Moreover, the methodology in this paper showcases a feasible way to characterize interdisciplinarity of research and measure the results of translation in drug research, and it can be adopted and improved for other domains, such as vaccine, medical devices.

The benefits of translating biomedical research at drug discovery institutes

The What And Why Of Translational Medicine

Translational Medicine: Advancing Medical Science by Stimulating Interdisciplinary Research

Create a translational medicine knowledge repository--research downsizing, mergers and increased outsourcing have reduced the depth of in-house translational medicine expertise and institutional memory at many pharmaceutical and biotech companies: how will they avoid relearning old lessons?

Investigating drug translational research using PubMed articles

Importance of scientific collaboration in contemporary drug discovery and development: a detailed network analysis

Characterizing interdisciplinarity in drug research: A translational science perspective

Navigating the oncology drug discovery and development process with programmes supported by the National Institutes of Health

Translational medicine--doing it backwards

Structural biology and bioinformatics in drug design: opportunities and challenges for target identification and lead discovery

Academic drug discovery: Challenges and opportunities

Poor Translatability of Biomedical Research Using Animals — A Narrative Review

Translational Medicine is Developing in China: a New Venue for Collaboration.

Lost in translation: the valley of death across preclinical and clinical divide – identification of problems and overcoming obstacles

Discovery in Clinical and Translational Medicine

A decade plus of translation: what do we understand?

Global Translational Medicine Initiatives and Programs

Translational Medicine Should Translate Medical Science and Technology into Health Care for Everyone in China

Hierarchy of Knowledge Translation: From Health Problems to Ad-Hoc Drug Design

Exploring NCATS in-house biomedical data for evidence-based drug repurposing

Institutional Infrastructure to Support Translational Research